Metamark Genetics, Inc. Names Dr. Peter Maimonis As Senior Vice President And Chief Science Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics, Inc. ("Metamark" or the "Company"), a leader in commercializing high value urologic oncology products, announced today that Peter Maimonis, Ph.D., has joined Metamark's leadership team as Senior Vice President and Chief Science Officer, effective October 7, 2015.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.